Image de couverture de livre

A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Maya Ball‐Burack, Andrew Menssen, Lisa Eidenschink Brodersen, Arun Nalla, Michael Loken, Laura Pardo, Ann Dahlberg, Chad Hudson, Soheil Meshinchi, Katherine Tarlock
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pediatric Blood & Cancer
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
par: Qiang Yao, et autres
Publié: (2025)

A Rare Case of Concurrent Neuroblastoma and Acute Myeloid Leukemia With CBFA2T3::GLIS2 Fusion: A Diagnostic and Therapeutic Dilemma
par: Laura M. Molina, et autres
Publié: (2025)

Emergence and Implications of DNMT3A Mutations in Pediatric AML Post‐HSCT: A Case Report and Literature Review
par: Aarushi Madan, et autres
Publié: (2025)

Creation of Blinatumomab Administration Standards: A Single Institution's Experience
par: Sue Zupanec, et autres
Publié: (2026)

Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission
par: Jonathan Moody, et autres
Publié: (2024)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
par: Eesha A. Zaheer, et autres
Publié: (2026)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
par: Angela Parra del Riego, et autres
Publié: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
par: Sue Zupanec, et autres
Publié: (2025)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
par: Krunal Shah, et autres
Publié: (2025)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
par: Reena Pabari, et autres
Publié: (2025)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model
par: Katelyn Oranges, et autres
Publié: (2026)

High‐throughput sequencing of archival cerebrospinal fluid specimens defines B‐lymphoblastic leukemia clonal composition
par: Karl Foley, et autres
Publié: (2024)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
par: Nicolò Peccatori, et autres
Publié: (2025)

Rapid Donor‐Specific Antibodies Clearance With Short‐Course Blinatumomab Prior to Haploidentical HSCT: A Case of Successful Engraftment
par: Zebin Luo, et autres
Publié: (2025)

Overcoming Chemotherapy Resistance in EBF1–PDGFRB‐Positive B‐ALL: A Novel Therapeutic Approach Using Dasatinib and Blinatumomab
par: Jinyu Fu, et autres
Publié: (2025)

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
par: Qiang Yao, et autres
Publié: (2025)

Sustained Remission in a Pediatric B‐Cell Acute Lymphoblastic Leukemia With Rare PAX5::KIAA1549L Fusion and Complex Karyotype Following Blinatumomab Consolidation
par: Xiaoyong Chen, et autres
Publié: (2025)

Concurrent Somatic Mutations of the SETBP1 and KRAS Genes in Pediatric AML: A Case Report
par: Ryo Okuse, et autres
Publié: (2026)

Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient
par: Ashley Carlo, et autres
Publié: (2024)

Deep Sequencing of FLT3 ‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study
par: Sofie Johansson Alm, et autres
Publié: (2026)

Seroreversion of Human Papilloma Virus Antibodies in a Childhood Solid Tumor Survivor Following Three‐Dose Vaccination
par: Yali Han, et autres
Publié: (2025)

Ifosfamide‐Related Optic Nerve Toxicity: Case Description and Review of the Literature
par: Nalla Silva Baticam, et autres
Publié: (2025)

Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective
par: Nivedita S. Prabhu, et autres
Publié: (2024)

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
par: Stephanie Fetzko, et autres
Publié: (2024)

Ifosfamide Neurotoxicity Revisited: Recurrence Triggered by Cyclophosphamide—A Rare Clinical Insight
par: Nishkala Uday Rao, et autres
Publié: (2025)

The Performance of the Australian–UK–Swiss Clinical Decision Rule for Febrile Neutropenia in Children and Young Adults With Bone and Soft Tissue Sarcomas
par: Arun K. Mahapatra, et autres
Publié: (2025)

Improving the Safety and Efficacy of Blood Product Administration in the Pediatric Hematology/Oncology Patient Population
par: Claudia J. Heller, et autres
Publié: (2026)

Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”
Publié: (2025)

Safety and Efficacy of Anticoagulation Therapy in Paediatric Patients With Solid Tumours or Lymphomas at Risk of Thrombocytopenia: A Retrospective Study
par: Andrés Felipe Fajardo, et autres
Publié: (2025)

Neurologic Morbidity in Survivors of Childhood Hodgkin Lymphoma Treated With Radiation
par: Raja B. Khan, et autres
Publié: (2026)

HABIT Efficacy Trial Intervention Improves Elements of General and Disease‐Specific Quality of Life in Youth With Sickle Cell Disease
par: Arlene Smaldone, et autres
Publié: (2025)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
par: Thomas J. Jackson, et autres
Publié: (2026)

Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
par: Erica Tonti, et autres
Publié: (2026)

Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk
par: Ji Yun Tark, et autres
Publié: (2025)

Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long‐Term Exposure While Maintaining Efficacy
par: Natalia Wojciechowska, et autres
Publié: (2025)

Waardenburg Syndrome With T‐Lymphoblastic Lymphoma: A Case Report
par: Neha Da Rocha, et autres
Publié: (2025)

Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial
par: Franco Locatelli, et autres
Publié: (2024)

Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study
par: Jiaoyang Cai, et autres
Publié: (2025)

Transplacentally acquired diffuse large B‐cell lymphoma in an infant: A diagnostic conundrum
par: Samipa Das, et autres
Publié: (2024)

Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of Neuroblastoma
par: Serena Y. Tan, et autres
Publié: (2024)